Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study

Vastra Gotaland Region15 enrolled

Overview

The aim is to conduct a single centre retrospective study of all patients with stage IV melanoma that underwent surgery for metastases at Sahlgrenska University Hospital between 2010-01-01 and 2018-12-31. Pre- and postoperative data will be collected from digital medical records, the Swedish Cancer Registry, the Swedish Cause of Death Register as well as from the national Swedish cancer patient database (INCA). If needed, patient records will be collected from other hospitals. Results will be presented in written format as a summary and analysis of the characteristics of the cases operated on during the inclusion period. The aim is to identify predictive and prognostic factors for outcome and complications in the surgical treatment of stage IV metastatic melanoma.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Melanoma Stage Iv Melanoma Metastatic Abdominal Tumor

Interventions

Abdominal surgery with metastasectomy

Emergency or elective surgery on indications related to abdominally metastasized malignant melanoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Biopsy verified stage IV malignant melanoma, stage M1c. * Having undergone surgery with metastasectomy of melanoma tumors. Exclusion Criteria: * retroperitoneal tumors

Locations (1)

Sahlgrenska University Hospital

Gothenburg, Sweden

Outcomes

Primary Outcomes

Overall survival

Time frame: December 2018

Secondary Outcomes

Complications according to Clavien-Dindo within 90 days.

Time frame: 90 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.